ReNeuron Group (ReNeuron Group) Price-to-Tangible-Book : 1.05 (As of Apr. 26, 2024)

View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group Price-to-Tangible-Book?

As of today (2024-04-26), ReNeuron Group's share price is $0.05055. ReNeuron Group's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was $0.05. Hence, ReNeuron Group's Price to Tangible Book Ratio of today is 1.05.

The historical rank and industry rank for ReNeuron Group's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, ReNeuron Group's highest Price to Tangible Book Ratio was 5.62. The lowest was 0.68. And the median was 1.80.

RNUGF's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.68
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, ReNeuron Group's share price is $0.05055. ReNeuron Group's Book Value per Sharefor the quarter that ended in Sep. 2023 was $0.05. Hence, ReNeuron Group's P/B Ratio of today is 0.97.

ReNeuron Group Price-to-Tangible-Book Historical Data

The historical data trend for ReNeuron Group's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Price-to-Tangible-Book Chart

ReNeuron Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.42

2.71

3.72

1.71

0.84

ReNeuron Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Tangible-Book	Get a 7-Day Free Trial															3.65	1.71	2.51	0.84	1.92

Competitive Comparison of ReNeuron Group's Price-to-Tangible-Book

For the Biotechnology subindustry, ReNeuron Group's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ReNeuron Group's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReNeuron Group's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's Price-to-Tangible-Book falls into.

ReNeuron Group Price-to-Tangible-Book Calculation

ReNeuron Group's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	0.05055	/	0.048
	=	1.05

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

ReNeuron Group Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group (ReNeuron Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

RENE.GB:UK RENE:UK RQE1:Germany

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.